Rexahn Pharmaceuticals (RNN) Jumps: Stock Rises 9.6%

Zacks Equity Research

Rexahn Pharmaceuticals, Inc. (RNN) was a big mover last session, as its shares rose almost 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $0.68 to $0.73 in the past one-month timeframe.

In the last 30 days, the company witnessed a mixed track record of one positive and one negative estimate revision while the Zacks Consensus Estimate moved slightly higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Rexahn Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the biomedical/gene industry include Gilead Sciences Inc. (GILD), Cambrex Corporation. (CBM) and China Biologic Products, Inc. (CBPO). All three sport a Zacks Rank #1 (Strong Buy).
    
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




REXAHN PHARMACEUTICALS INC (RNN): Free Stock Analysis Report

GILEAD SCIENCES INC (GILD): Free Stock Analysis Report

CAMBREX CORP (CBM): Free Stock Analysis Report

CHINA BIOLOGIC PRODUCTS INC (CBPO): Free Stock Analysis Report


Zacks Investment Research